WATERTOWN, Mass.--(BUSINESS WIRE)--Sept. 19, 2006--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the UBS Global Life Sciences Conference to be held at the Grand Hyatt in New York, NY September 25-28. Peyton J. Marshall, Panacos’ Acting CEO, will give a corporate overview on September 26 at 1:00 p.m. ET.
